Clinical Trial Update: Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis

View source ↗

Summary

A completed study by GlaxoSmithKline examining demographic, pharmacologic, biomarker, clinical features, and quality of life in participants with lupus nephriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED | Results posted: 2026-01-22